Company Profiles

driven by the PitchBook Platform

Color Genomics

Color Genomics
2013 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series C LATEST DEAL TYPE
$89.4M LATEST DEAL AMOUNT
38 INVESTORS
Description

Developer of genetic testing kits created to screen for hereditary health issues. The company's testing kits can be purchased online and include a device to provide a saliva sample that is sent back in a postage-paid package where it will be analyzed and provide a record of hereditary disorders along with personalized screening guidelines, enabling users to take control of their health and create a personalized healthcare plan.

Website
Formerly Known As
Color Global
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Social/Platform Software
Other Industries
Other Healthcare Services
Internet Retail
Primary Office
1801 Murchison Drive
Suite 128
Burlingame, CA 94010
United States

+1 (844) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Color Genomics’s full profile, request a free trial.

Color Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 14-Nov-2017 $89.4M 00000 00000 Completed Generating Revenue
3. Early Stage VC (Series B) 27-Sep-2016 0000 0000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 21-Apr-2015 $15M $15M 0000 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Color Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
Series B 7,790,000 $0.000100 $0.39 $6.44 $6.44 1x $6.44 23.24%
Series A 6,536,934 $0.000100 $0.21 $3.46 $3.46 1x $3.46 19.5%
To view this company’s complete Cap Table, request access »

Color Genomics Investors (38)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Charles River Ventures Venture Capital Minority 000 0000 000000 0
Fenox Venture Capital Venture Capital Minority 000 0000 000000 0
Foresite Capital Management Growth/Expansion Minority 000 0000 000000 0
Emerson Collective Impact Investing Minority 000 0000 000000 0
General Catalyst Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 38 investors. Get the full list »

Color Genomics Executive Team (9)

Name Title Board
Seat
Contact
Info
Othman Laraki Co-Founder, Board Member and Chief Executive Officer
Jill Hagenkord MD Chief Executive Officer
Tony Wang JD Chief Operating Officer
Taylor Sittler MD Chief Scientific Officer & Co-Founder
Nish Bhat Co-Founder & Founding Engineer

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

Color Genomics Board Members (4)

Name Representing Role Since Contact
Info
Elad Gil Ph.D Color Genomics Co-Founder & Chairman 000 0000
Hemant Taneja General Catalyst Partners Board Member 000 0000
Othman Laraki Color Genomics Co-Founder, Board Member and Chief Executive Officer 000 0000
Susan Wagner Self Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com